Chapter 16. Membrane and soluble pattern recognition receptors: The unique functions of the long pentraxin PTX3

Clinical and Experimental Allergy Reviews

Volumn 4, Issue SUPPL. 2, 2004, Pages 150-154

  Mantovani, Alberto ^a,b,c   Garlanda, C ^a   Otero, K ^a   Peri, G ^a   Vecchi, A ^a   Bottazzi, B ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ist Ric Farmacologiche Mario Negri ^*  (Italy)

Author keywords

Autoimmune disorders; Fertility; Inflammation; Innate immunity; Pattern recognition receptors; Pentraxins

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PENTRAXIN; PENTRAXIN 3; SERUM AMYLOID P; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CELL TYPE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DENDRITIC CELL; ENDOTHELIUM CELL; FEMALE FERTILITY; GENE FUNCTION; HUMAN; IMMUNOREGULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; LIGAND BINDING; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PTX3 GENE; RECEPTOR GENE;

EID: 11844275311     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-9725.2004.00048.x     Document Type: Conference Paper

References (53)

1. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-45.
2. Muzio M, Mantovani A. Toll-like receptors. Microbes Infect 2000; 2:251-5.
3. Emsley J, White HE, O'Hara BP et al. Structure of pentameric human serum amyloid P component. Nature 1994; 367:338-45.
4. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
5. Steel DM, Whitehead AS. The major acute phase reactants. C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15:81-8.
6. Schwalbe RAB, Dahlback JE Coe et al. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 1992; 31:4907-15.
7. Hicks PS, Saunero Nava L, Du Clos TW et al. Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol 1992; 149:3689-94.
8. Pepys MB, Butler PJ. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun 1987; 148:308-13.
9. Butler PJ, Tennent GA, Pepys MB. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J Exp Med 1990; 172:13-8.
10. Loveless RW, Floyd OS, Raynes JG et al. Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid. EMBO J 1992; 11:813-9.
11. Volanakis JE. Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389:235-50.
12. Ying SC, Gewurz AT, Jiang H et al. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of Clq. J Immunol 1993; 150:169-76.
13. Jiang H, Siegel JN, Gewurz H. Binding and complement activation by C-Reactive protein via the collagen-like region of Clq and inhibition of these reactions by monoclonal antibodies to C-reactive protein and Clq. J Immunol 1991; 146:2324-30.
14. Jiang H, Robey FA, Gewurz H. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human Clq A chain. J Exp Med 1992; 175:1373-9.
15. Bristow CL, Boackle RJ. Evidence for the binding of human serum amyloid P component to Clq and Fab gamma. Mol Immunol 1986; 23:1045-52.
16. Pepys MB, Dyck RF, de Beer FC et al. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 1979; 38:284-93.
17. de Beer FC, Baltz ML, Holford S et al. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med 1981; 154:1134-9.
18. Garcia de Frutos P, Hardig Y, Dahlback B, Serum amyloid P component binding to C 4b-binding protein. J Biol Chem 1995; 270:26950-5.
19. +-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate [published erratum appears in J Biol Chem 1987 June 25; 262 (18): 8940]. J Biol Chem 1987; 262:1456-60.
20. +-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate [published erratum appears in J Biol Chem 1987 June 25; 262 (18): 8940]. J Biol Chem 1987; 262:1456-60.
21. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxis) and serum amyloid A protein. Adv Immunol 1983; 34:141-212.
22. Breviario F, d'Aniello EM, Golay J et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267:22190-7.
23. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J Immunol 1993; 150:1804-12.
24. Vidal Alles V, Bottazzi B, Peri G et al. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994; 84:3483-93.
25. Lee GW, Goodman AR, Lee TH et al. Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins. J Immunol 1994; 153:3700-7.
26. Introna M, Vidal Alles V, Castellano M et al. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996; 87:1862-72.
27. Bottazzi B, Vouret-Craviari V, Bastone A et al. Multimer formation and ligand recognition by the long pentraxin PTX3-similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997; 272:32817-23.
28. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410:50-6.
29. Reid MS, Blobel CP. Apexin, an acrosomal pentaxin. J Biol Chem 1994; 269:32615-20.
30. Noland TD, Friday BB, Maulit MT et al. The sperm acrosomal matrix contains a novel member of the pentaxin family of calcium-dependent binding proteins. J Biol Chem 1994; 269:32607-14.
31. Seery LT, Schoenberg DR, Barbaux S et al. Identification of a novel member of the pentraxin family in Xenopus laevis. Proc Roy Soc Lond B Biol Sci 1993; 253:263-70.
32. Schlimgen AK, Helms JA, Vogel H et al. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system. Neuron 1995; 14:519-26.
33. Omeis IA, Hsu YC, Perin MS. Mouse and human neuronal pentraxin 1 (NPTX1): conservation, genomic structure, and chromosomal localization. Genomics 1996; 36:543-5.
34. Hsu YC, Perin MS. Human neuronal pentraxin II (NPTX2). Conservation, genomic structure, and chromosomal localization. Genomics 1995; 28:220-7.
35. Tsui CC, Copeland NG, Gilbert DJ et al. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dinamically regulated by neuronal activity. J Neurosci 1996; 15:2463-78.
36. Dodds DC, Omeis IA, Cushman SJ et al. Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxin-associated calcium-binding protein 49. J Biol Chem 1997; 272:21488-94.
37. Kirkpatrick LL, Matzuk MM, Dodds DC et al. Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J Biol Chem 2000; 275:17786-92.
38. Basile A, Sica A, D'Aniello E et al. Characterization of the promoter for the human long pentraxin PTX3. J Biol Chem 1997; 272:8172-8.
39. Altmeyer A, Klampfer L, Goodman AR et al. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor interleukin-1-inducible pentraxin protein. J Biol Chem 1995; 270:25584-90.
40. Polentarutti N, Bottazzi B, Di Santo E et al. Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol 2000; 106:87-94.
41. Goodman AR, Levy D, Reis LF et al. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J Leukoc Biol 2000; 67:387-95.
42. Vouret-Craviari V, Matteucci C, Peri G et al. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect Immun 1997; 65:1345-50.
43. Polentarutti N, Picardi G, Basile A et al. Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes and endothelial cells. Eur J Immunol 1998; 28:496-501.
44. Goodman AR, Cardozo T, Abagyan R et al. Long pentraxins: an emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996; 7:191-202.
45. Agnello D, Carvelli L, Muzio V et al. Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram. J Neuroimmunol 2000; 109:105-11.
46. Ravizza T, Moneta D, Bottazzi B et al. Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience 2001; 105:43-53.
47. Garlanda C, Hirsch E, Bozza S et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-6.
48. Muller B, Peri G, Doni A et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29:1404-7.
49. Peri G, Introna M, Corradi D et al. PTX3, a prototypic long pentraxin, is an early indicator of acute myocardial infarction in man. Circulation 2000; 102:636-41.
50. Luchetti MM, Piccinini G, Mantovani A et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 2000; 119:196-202.
51. Fazzini F, Peri G, Doni A et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 2001; 44:2841-50.
52. Malaguarnera L, Pilastro MR, Vicari L et al. PTX3 gene expression in Castleman's disease. Eur J Haematol 2000; 64:132-4.
53. Rovere P, Peri G, Fazzini F et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 2000; 96:4300-6.